Anil Bhanudas Gaikwad Selected Research

esculetin

11/2017	Esculetin ameliorates vascular perturbation by intervening in the occupancy of H2BK120Ub at At1, At2, Tgfβ1 and Mcp1 promoter gene in thoracic aorta of IR and T2D rats.
9/2017	Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.
8/2017	Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway.
12/2016	Esculetin: A phytochemical endeavor fortifying effect against non-communicable diseases.
10/2015	Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis.
5/2015	Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anil Bhanudas Gaikwad Research Topics

Disease

13	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2009
10	Fibrosis (Cirrhosis) 01/2021 - 10/2015
8	Insulin Resistance 08/2022 - 05/2007
8	Inflammation (Inflammations) 01/2022 - 04/2016
5	Diabetic Cardiomyopathies 10/2019 - 09/2017
4	Neoplasms (Cancer) 01/2020 - 12/2016
4	Renal Insufficiency (Renal Failure) 11/2017 - 03/2010
4	Type 2 Diabetes Mellitus (MODY) 10/2015 - 03/2010
3	Hyperglycemia 03/2022 - 05/2007
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2022 - 05/2015
3	Kidney Diseases (Kidney Disease) 01/2022 - 01/2021
3	Heart Failure 01/2019 - 03/2007
3	Obesity 06/2017 - 04/2016
2	Chronic Renal Insufficiency 01/2022 - 06/2017
2	Necrosis 01/2021 - 10/2017
2	Diabetes Mellitus 12/2020 - 10/2019
2	Cardiomyopathies (Cardiomyopathy) 09/2017 - 03/2010
2	Atherosclerosis 06/2017 - 04/2016
2	Hypertrophy 03/2010 - 01/2009
1	Acidosis 08/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Reperfusion Injury 01/2022
1	Diabetes Complications 01/2021
1	Wounds and Injuries (Trauma) 11/2020
1	Ischemia 09/2020
1	Severe Acute Respiratory Syndrome 01/2020
1	COVID-19 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 02/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Idiopathic Pulmonary Fibrosis 11/2017
1	Ischemic Stroke 11/2017
1	Myocardial Infarction 11/2017
1	Rare Diseases (Rare Disease) 11/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 08/2017
1	Non-alcoholic Fatty Liver Disease 08/2017
1	Angioedema 06/2017
1	Nervous System Diseases (Neurological Disorders) 12/2016

Drug/Important Bio-Agent (IBA)

8	Histones (Histone)IBA 12/2020 - 03/2010
6	Streptozocin (Streptozotocin)FDA Link 10/2019 - 05/2007
6	Telmisartan (Micardis)FDA Link 03/2019 - 04/2010
6	esculetinIBA 11/2017 - 05/2015
4	Angiotensin-Converting Enzyme 2IBA 03/2022 - 11/2015
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2017
4	Neprilysin (Neutral Endopeptidase)IBA 10/2019 - 01/2019
4	Insulin (Novolin)FDA Link 06/2017 - 05/2007
3	Angiotensin Receptor AntagonistsIBA 11/2021 - 11/2017
3	AntioxidantsIBA 11/2020 - 08/2017
3	Type 2 Angiotensin ReceptorIBA 09/2020 - 10/2017
3	Fibronectins (Fibronectin)IBA 09/2017 - 01/2015
3	Angiotensin IIIBA 04/2016 - 05/2007
2	CytokinesIBA 08/2022 - 01/2021
2	EnzymesIBA 08/2022 - 06/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2015
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2019 - 11/2015
2	ThiorphanIBA 03/2019 - 01/2019
2	Natriuretic PeptidesIBA 03/2019 - 01/2019
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2019 - 12/2016
2	Caspase 3 (Caspase-3)IBA 01/2019 - 10/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2018 - 04/2010
2	compound 21IBA 11/2017 - 10/2017
2	Peptides (Polypeptides)IBA 11/2017 - 10/2017
2	Lysine (L-Lysine)FDA Link 10/2017 - 12/2016
2	CollagenIBA 08/2017 - 01/2015
2	ChromatinIBA 12/2016 - 06/2010
1	FructoseIBA 08/2022
1	LigandsIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Toll-Like Receptor 4IBA 01/2022
1	Toll-Like Receptor 2IBA 01/2022
1	HMGB1 Protein (HMG1)IBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Oxidants (Oxidizing Agents)IBA 11/2020
1	talazoparibIBA 01/2020
1	rucaparibIBA 01/2020
1	olaparibIBA 01/2020
1	niraparibIBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	SodiumIBA 02/2019
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2019
1	SilverIBA 11/2017
1	CaspasesIBA 10/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2017
1	Caspase 8 (Caspase-8)IBA 10/2017
1	Caspase 7IBA 10/2017
1	TransferasesIBA 10/2017
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2017
1	FatsIBA 08/2017
1	omapatrilatIBA 06/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2017
1	UbiquitinIBA 06/2017
1	Antihypertensive Agents (Antihypertensives)IBA 06/2017

Therapy/Procedure

8	Therapeutics 11/2020 - 08/2017
2	Drug Therapy (Chemotherapy) 06/2017 - 04/2010
1	Diet Therapy (Therapy, Diet) 01/2021